-
Get the latest information and research on osteoporosis.
-
Find treatment, guidance and advice on living with osteoporosis.
-
Share your experience and get involved. Joining the conversation is the first step to ending osteoporosis and broken bones.
Following is a statement by the National Osteoporosis Foundation on the U.S. Food and Drug Administration’s clearance for Optasia Medical’s SpineAnalyzer™
WASHINGTON, DC (February 22, 2011) — Osteoporosis is a serious, widespread and growing public health threat, according to the National Osteoporosis Foundation (NOF). When the disease is undiagnosed or untreated, it is marked by broken bones (fractures) which cause pain, disability and in some cases, reduced lifespan.
On February 4, 2011, the Optasia Medical SpineAnalyzer was cleared by the FDA. SpineAnalyzer is a tool that helps healthcare providers to identify broken bones in the spine. Patients with spinal fractures can then be treated for osteoporosis which reduces the risk for future fractures.
NOF welcomes any new FDA approved diagnostic options, such as SpineanalyzerTM, that will help patients address this prevalent disease. NOF estimates 10 million Americans have osteoporosis and another 34 million are at risk for the disease.
About the National Osteoporosis Foundation
Established in 1984, the National Osteoporosis Foundation, a leading community-focused health organization, is dedicated to the prevention of osteoporosis and broken bones, the promotion of strong bones for life and the reduction of human suffering through programs of awareness, education, advocacy and research. For more information on the National Osteoporosis Foundation, visit www.nof.org.
The latest
The National Osteoporosis Foundation has named Barbara Hannah Grufferman as its first Bone Health Ambassador. In this newly-established role, Grufferman, a well-known advocate for healthy and positive living, will dedicate her time, talent and energy to raise awareness for osteoporosis and the importance of building strong bones for life.
Thanks to a generous gift from The Samuel J. & Ethel LeFrak Charitable Trust, the National Osteoporosis Foundation met its Generations of Strength fundraising goal one year early. NOF launched the Generations of Strength initiative in September 2011 with the goal of raising $2 million in two years to improve patient care for the most vulnerable – those who have broken bones due to osteoporosis – and to protect future generations from the disease.
The National Osteoporosis Foundation (NOF), the nation’s leading health organization dedicated to preventing osteoporosis and broken bones, has named Claire Gill as its Senior Director of Marketing, Consumer and Corporate Outreach. Gill brings extensive experience in public relations and marketing communications to this newly-established role.
